Turnover: 321.6 million USD (2020)
Country: United States
In 2010, Syneron Medical Ltd, manufacturer of energy-based aesthetic medical devices, merged with Candela Corp, manufacturer and owner of laser technologies. The result is Syneron Candela, 80% owned by Syneron Medical Ltd and 20% by Candela.
The company offers products in three segments and under three different brands: Syneron, Candela and CoolTouch. It also has flagship devices and products such as the UltraShape, VelaShape, VBeamPerfecta and PicoWay. The group offers its products in 86 countries and has offices in Europe,the USA, China, Japan, Australia and Hong Kong.
In 2017, the group was acquired by private equity fund ApaxPartners at a valuation of $397 million.
Financial Data
DUNS: 350323416
Legal Name: CANDELA
Address: 12 AVENUE DE SCANDINAVIE PARC VICTORIA. IMMEUBLE LE TORONTO, 91940 LES ULIS
Number of employees: Entre 20 et 49 salariés (2021)
Capital: 1 230 100 EUR
Financial Data:
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 19 194 588 | 12 674 243 | 12 430 685 | 11 846 483 | 7 966 043 | 7 291 942 | 6 348 357 | 4 322 870 | 4 793 365 | 5 994 057 |
| Gross margin (€) | 8 327 964 | 7 030 393 | 5 166 153 | 5 211 214 | 4 626 499 | 4 082 339 | 3 813 570 | 3 502 107 | 2 509 847 | 3 300 169 |
| EBITDA (€) | 460 512 | 893 459 | 236 058 | -84 745 | 446 873 | 136 919 | 513 898 | -382 087 | 737 111 | 775 225 |
| Operating profit (€) | 697 577 | 1 485 804 | 249 189 | 355 316 | 479 382 | 189 284 | 73 264 | -62 591 | 513 737 | 392 481 |
| Net profit (€) | 373 498 | 1 054 566 | 272 179 | 71 370 | 370 701 | 195 169 | 111 290 | -52 577 | 272 956 | 241 457 |
| Turnover growth rate (%) | 51,4 | 2 | 4,9 | 48,7 | 9,2 | 14,9 | 46,9 | -9,8 | -20 | - |
| Ebitda margin rate (%) | 2,4 | 7 | 1,9 | -0,7 | 5,6 | 1,9 | 8,1 | -8,8 | 15,4 | 12,9 |
| Operating margin rate (%) | 3,6 | 11,7 | 2 | 3 | 6 | 2,6 | 1,2 | -1,4 | 10,7 | 6,5 |
| Working Capital (turnover days) | 23,1 | 38,1 | 95,4 | 95,6 | 143,8 | 199,4 | 194,2 | 226,1 | 191,1 | 214,5 |
| Working Capital requirements (turnover days) | 114,7 | 160,9 | 157,8 | 203,9 | 127 | 137,9 | 95,6 | 237,7 | 202,3 | 231,6 |
| Net margin (%) | 1,9 | 8,3 | 2,2 | 0,6 | 4,7 | 2,7 | 1,8 | -1,2 | 5,7 | 4 |
| Added value / Turnover (%) | 25,9 | 35,2 | 26,3 | 22,4 | 32,2 | 30,9 | 33,2 | 24,1 | 44,5 | 37,3 |
| Wages and social charges (€) | 4 397 058 | 3 463 395 | 2 897 569 | 2 627 577 | 2 035 450 | 2 020 771 | 1 528 135 | 1 374 428 | 1 331 604 | 1 386 680 |
| Salaries / Turnover (%) | 22,9 | 27,3 | 23,3 | 22,2 | 25,6 | 27,7 | 24,1 | 31,8 | 27,8 | 23,1 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Gérant | Geoffrey, Schuyler | Crouse | 54 | |
| Gérant | Ernest | Orticerio | 61 |
Studies mentioning this company
The aesthetic medicine market - France
Other companies mentioned:
- Allergan plc
- Galderma
- Merz Pharmaceuticals
- La Roche-Posay
- Filorga Cosmétiques (Colgate Palmolive)
- Lierac (Laboratoire Native)
- Laboratoires Sebbin
- Arion
- Candela Medical
- Deleo
- Ipsen
- Clinique des Champs Elysées
- Lazeo
- Maison Lutetia
- Skincareagency